Financials Lana Medical Company
Equities
9587
SA15TGFKLPH6
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.8 SAR | -1.28% |
|
-3.45% | -3.75% |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Net sales 1 | 31.97 | 40.8 |
EBITDA 1 | 8.088 | 7.535 |
EBIT 1 | 7.319 | 6.523 |
Operating Margin | 22.9% | 15.99% |
Earnings before Tax (EBT) 1 | 7.791 | 6.62 |
Net income 1 | 6.594 | 5.493 |
Net margin | 20.63% | 13.46% |
EPS 2 | 3.014 | 1.831 |
Free Cash Flow | - | -1.798 |
FCF margin | - | -4.41% |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 10/3/23 | 10/3/23 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 |
---|---|---|
Net Debt 1 | 5.23 | 4.92 |
Net Cash position 1 | - | - |
Leverage (Debt/EBITDA) | 0.6462 x | 0.6528 x |
Free Cash Flow | - | -1.8 |
ROE (net income / shareholders' equity) | - | 12.3% |
ROA (Net income/ Total Assets) | - | 6.77% |
Assets 1 | - | 81.17 |
Book Value Per Share 2 | 19.00 | 15.80 |
Cash Flow per Share 2 | 1.610 | 1.100 |
Capex 1 | 7.22 | 5.1 |
Capex / Sales | 22.58% | 12.5% |
Announcement Date | 10/3/23 | 10/3/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-3.75% | 29.56M | |
-13.97% | 8.34B | |
+14.29% | 1.45B | |
-5.71% | 1.36B | |
-28.70% | 1.05B | |
-33.75% | 695M | |
-.--% | 622M | |
+4.78% | 469M | |
+1.02% | 427M | |
-37.14% | 278M |
- Stock Market
- Equities
- 9587 Stock
- Financials Lana Medical Company